229 related articles for article (PubMed ID: 35692124)
1. Carbon-ion radiotherapy for urological cancers.
Ishikawa H; Hiroshima Y; Kanematsu N; Inaniwa T; Shirai T; Imai R; Suzuki H; Akakura K; Wakatsuki M; Ichikawa T; Tsuji H
Int J Urol; 2022 Oct; 29(10):1109-1119. PubMed ID: 35692124
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
4. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
5. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
[TBL] [Abstract][Full Text] [Related]
6. Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan.
Inaniwa T; Kanematsu N; Matsufuji N; Kanai T; Shirai T; Noda K; Tsuji H; Kamada T; Tsujii H
Phys Med Biol; 2015 Apr; 60(8):3271-86. PubMed ID: 25826534
[TBL] [Abstract][Full Text] [Related]
7. Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment.
Zakaria AM; Colangelo NW; Meesungnoen J; Azzam EI; Plourde MÉ; Jay-Gerin JP
Radiat Res; 2020 Dec; 194(6):587-593. PubMed ID: 32853343
[TBL] [Abstract][Full Text] [Related]
8. Functional imaging-guided carbon ion irradiation with simultaneous integrated boost for localized prostate cancer: study protocol for a phase II randomized controlled clinical trial.
Hu W; Li P; Hong Z; Guo X; Pei Y; Zhang Z; Zhang Q
Trials; 2022 Nov; 23(1):934. PubMed ID: 36348363
[TBL] [Abstract][Full Text] [Related]
9. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
[TBL] [Abstract][Full Text] [Related]
10. Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
Glowa C; Peschke P; Brons S; Neels OC; Kopka K; Debus J; Karger CP
Radiat Oncol; 2017 Nov; 12(1):174. PubMed ID: 29121984
[TBL] [Abstract][Full Text] [Related]
11. Particle therapy for prostate cancer: The past, present and future.
Ishikawa H; Tsuji H; Murayama S; Sugimoto M; Shinohara N; Maruyama S; Murakami M; Shirato H; Sakurai H
Int J Urol; 2019 Oct; 26(10):971-979. PubMed ID: 31284326
[TBL] [Abstract][Full Text] [Related]
12. A review of update clinical results of carbon ion radiotherapy.
Tsujii H; Kamada T
Jpn J Clin Oncol; 2012 Aug; 42(8):670-85. PubMed ID: 22798685
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
[TBL] [Abstract][Full Text] [Related]
14. Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
Habl G; Hatiboglu G; Edler L; Uhl M; Krause S; Roethke M; Schlemmer HP; Hadaschik B; Debus J; Herfarth K
BMC Cancer; 2014 Mar; 14():202. PubMed ID: 24641841
[TBL] [Abstract][Full Text] [Related]
15. Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies.
Du TQ; Liu R; Zhang Q; Luo H; Chen Y; Tan M; Wang Q; Wu X; Liu Z; Sun S; Yang K; Tian J; Wang X
Eur J Med Res; 2022 Dec; 27(1):306. PubMed ID: 36572945
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
17. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of fractionated carbon ion treatments in three rat prostate tumors differing in growth rate, differentiation and hypoxia.
Glowa C; Peschke P; Brons S; Debus J; Karger CP
Radiother Oncol; 2021 May; 158():131-137. PubMed ID: 33587966
[TBL] [Abstract][Full Text] [Related]
19. Carbon-ion radiation therapy for prostate cancer.
Ishikawa H; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
Int J Urol; 2012 Apr; 19(4):296-305. PubMed ID: 22320843
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
